1. Home
  2. PEBO vs MPLT Comparison

PEBO vs MPLT Comparison

Compare PEBO & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peoples Bancorp Inc.

PEBO

Peoples Bancorp Inc.

N/A

Current Price

$39.48

Market Cap

1.4B

Sector

Finance

ML Signal

N/A

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

N/A

Current Price

$11.32

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PEBO
MPLT
Founded
1902
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.7B
IPO Year
2005
2025

Fundamental Metrics

Financial Performance
Metric
PEBO
MPLT
Price
$39.48
$11.32
Analyst Decision
Buy
Strong Buy
Analyst Count
3
7
Target Price
$37.33
$32.67
AVG Volume (30 Days)
194.6K
522.1K
Earning Date
04-21-2026
05-28-2026
Dividend Yield
4.94%
N/A
EPS Growth
N/A
82.39
EPS
1.59
N/A
Revenue
$197,000.00
N/A
Revenue This Year
$17.29
N/A
Revenue Next Year
$2.97
N/A
P/E Ratio
$25.19
N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.49
$9.10
52 Week High
$42.29
$40.43

Technical Indicators

Market Signals
Indicator
PEBO
MPLT
Relative Strength Index (RSI) 52.00 35.27
Support Level $38.86 $10.67
Resistance Level $41.59 $14.22
Average True Range (ATR) 0.51 0.90
MACD 0.04 0.38
Stochastic Oscillator 86.55 1.25

Price Performance

Historical Comparison
PEBO
MPLT

About PEBO Peoples Bancorp Inc.

Peoples Bancorp Inc (Marietta OH) is a financial holding company. As a community bank, it offers a complete line of banking, insurance, investment, and trust solutions through its financial subsidiaries. It offers demand deposit accounts, savings accounts, real estate mortgage loans, merchant credit card transaction processing services, corporate and personal trust services, life, health, property, and casualty insurance products, and brokerage services. The bank also offers telephone and internet-based banking through both personal computers and mobile devices.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: